Literature DB >> 15593394

Treatment of 140 cerebral palsied children with a combined method based on traditional Chinese medicine (TCM) and western medicine.

Xue-juan Zhou1, Kun Zheng.   

Abstract

OBJECTIVE: To observe and evaluate a method that is effective and practical for treatment of cerebral palsied (CP) children in China.
METHOD: The patient's age and disease type and individual specific conditions were considered in choosing therapy methods accordingly: Chinese herbs, acupuncture, auricular seed pressure, point finger pressing, massage, orthopedic hand manipulation, physiotherapy, occupational therapy, language therapy, etc. Meanwhile we created a new CP treatment model that combines hospitalized treatment with family therapy.
RESULTS: The majority of CP patients improved greatly in motor and social adaptation capacities after treatment. Wilcoxon paired rank sum test analysis showed that there were significant differences between the data before and after treatment (P<0.01).
CONCLUSION: This combined therapy method, based on traditional Chinese medicine and western medicine plus family supplemental therapy, is an effective and practical treatment strategy for CP children in China.

Entities:  

Mesh:

Year:  2005        PMID: 15593394      PMCID: PMC1390761          DOI: 10.1631/jzus.2005.B0057

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  3 in total

1.  Cerebral palsy trends. Implications for perinatal care.

Authors:  F J Stanley
Journal:  Acta Obstet Gynecol Scand       Date:  1994-01       Impact factor: 3.636

2.  [75 infantile palsy children treated with acupuncture, acupressure and functional training].

Authors:  X J Zhou; T Chen; J T Chen
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1993-04

Review 3.  Impact of improved survival of very low birth weight infants on recent secular trends in the prevalence of cerebral palsy.

Authors:  V Bhushan; N Paneth; J L Kiely
Journal:  Pediatrics       Date:  1993-06       Impact factor: 7.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.